Startseite>>Signaling Pathways>> Immunology/Inflammation>> IFNAR>>IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

Katalog-Nr.GC31799

IFN alpha-IFNAR-IN-1 (Interaktionsinhibitor von IFN-alpha und IFNAR) ist ein nichtpeptidischer, niedermolekularer Inhibitor der Wechselwirkung zwischen IFN-α und IFNAR; MVA-induziertes IFN-α hemmen; Antworten von BM-pDCs (IC50 = 2-8 uM).

Products are for research use only. Not for human use. We do not sell to patients.

IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor) Chemische Struktur

Cas No.: 844882-93-5

Größe Preis Lagerbestand Menge
5mg
101,00 $
Auf Lager
10mg
155,00 $
Auf Lager
50mg
449,00 $
Auf Lager
100mg
782,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

IFN alpha-IFNAR-IN-1 is a nonpeptidic, low-molecular-weight inhibitor of the interaction between IFN-α and IFNAR; inhibit MVA-induced IFN-α responses by BM-pDCs (IC50=2-8 uM).IC50 value:Target: IFN alpha-IFNAR interaction inhibitorIFN alpha-IFNAR-IN-1 specifically inhibits MVA-induced IFN-α responses by BM-pDCs. IFN alpha-IFNAR-IN-1 inhibited the IFN-α responses that were elicited after treatment with CpG2216, stimulation with poly(I:C), and infection with VSV-M2, whereas the total IL-12 production was notably less affected under those conditions. IFN alpha-IFNAR-IN-1 exerts immunosuppressive activity by the direct interaction with IFN-α [1].

[1]. Geppert T, et al. Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions. Angew Chem Int Ed Engl. 2012 Jan 2;51(1):258-61.

Chemical Properties of IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

Cas No. 844882-93-5 SDF
Canonical SMILES CNCC1=CC=CC=C1SC2=C(C=CC=C3)C3=CC=C2
Formula C18H17NS M.Wt 279.4
Löslichkeit Soluble in DMSO Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 3.5791 mL 17.8955 mL 35.791 mL
5 mM 0.7158 mL 3.5791 mL 7.1582 mL
10 mM 0.3579 mL 1.7895 mL 3.5791 mL
  • Molaritätsrechner

  • Verdünnung-Rechner

  • Molecular Weight Calculator

Gewicht
=
Konzentration
x
Inhalt
x
MW*
 
 
 
**Bei der Herstellung von Stammlösungen ist immer das chargenspezifische Molekulargewicht von

Berechnen

In vivo Formulation Calculator (Clear solution) of IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Bewertungen

Review for IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for IFN alpha-IFNAR-IN-1 (IFN-alpha and IFNAR interaction inhibitor)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.